Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways. [electronic resource]
- The Journal of clinical investigation Jan 2015
- 141-56 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.